April 2026 Newsletter

Our global, grassroots effort brings new hope to families affected by Aspartylglucosaminuria

We are thrilled to share that the U.S. Food and Drug Administration (FDA) has given approval to the start of a clinical trial for the treatment of the ultra-rare disease Aspartylglucosaminuria (AGU) 🧬✨

2025 Holiday Newsletter

Help Us Bring our AGU Kids One Step Closer to Treatment! As we enter this Holiday Season, we’re reminded that every act of giving—large or small—moves our children with Aspartylglucosaminuria (AGU) closer to the life-changing treatment they urgently need. We invite you to stand with our families, researchers, and our incredible global community as weContinue reading “2025 Holiday Newsletter”

2024 Happy Holidays From Rare Trait Hope Society!

As we wrap up an incredible year, we at Rare Trait Hope Society want to thank you 🙏 our valued supporters and sponsors đź«¶ for being the heart of our mission. Through your generosity, we’re making strides in advancing hope for those impacted by Aspartylglucosaminuria (AGU) and other rare conditions. This holiday newsletter shares excitingContinue reading “2024 Happy Holidays From Rare Trait Hope Society!”